This study is investigating the medication solrikitug for its safety and effective treatment of asthma in adults. This drug works by blocking a chain reaction in the immune system that contributes to inflammation, which can lead to a flare-up.
How the RAINIER study works
Qualifying participants will be enrolled at a local study site, where healthcare professionals will oversee the under-the-skin injection of either the study drug or a placebo. This study takes place over a total of 12 weeks.
Interested in learning more? Take the survey and find out if you are prequalified in just minutes.
Asthma can cause shortness of breath, wheezing, chronic coughing, and chest tightness. Any of these symptoms can stand in the way of a great day or a good night's sleep.
Are you constantly worried about asthma triggers?
Asthma sufferers are often sensitive to common allergens like dust or pollen, and it can be hard to know when symptoms can be triggered.
Is asthma holding you back?
Other symptoms of asthma might include difficulty sleeping, feeling fatigued, difficulty exercising, anxiety, and more.
The RAINIER clinical study is investigating a potential treatment that may help reduce some symptoms of asthma. To find out how you may be able to participate, click the button below.
Is the RAINIER clinical study for asthma right for you?
Adults between the ages of 18 and 75
Diagnosed with asthma for at least 12 months
No history of other chronic diseases
Other criteria apply. If you are interested in learning more, take the short survey below. You'll find out right away if you prequalify, and what the next steps may be.
If you're interested in participating in the RAINIER study, take the brief survey below. You'll find out right away if you are prequalified, and what will happen next.
